Metabolomic Study in Exhaled Breath Condensate of Thoracic Surgical Patients
1 other identifier
observational
40
1 country
1
Brief Summary
Acute lung injury (ALI) following thoracic surgery remains a major source of morbidity and mortality after lung resection. One-lung ventilation (OLV) is usually required in thoracic surgery. OLV is also an important predictor of postoperative ALI. Recent laboratory findings suggested that tissue hypoxemia and ischemia / reperfusion injury of the collapsed lungs during OLV is the major cause of lung injury. Exhaled Breath Condensate (EBC), which is the exhalate from breath typically collected by cooling device, contains most molecules found in the airway. Metabolomics refers to systematic and scientific study of chemical processes involving metabolites. This study will collect EBC for metabolomic analysis and aim to elucidate the biochemical reactions during one-lung ventilation and pathological mechanisms of acute lung injury following thoracic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2015
CompletedFirst Posted
Study publicly available on registry
October 22, 2015
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedMay 25, 2016
May 1, 2016
1 year
October 14, 2015
May 24, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with acute lung injury following thoracic surgery
30 days
Secondary Outcomes (1)
Metabolome of exhaled breath condensate associated with lung injury in thoracic surgery
5 hours
Study Arms (2)
Thoracic Surgery with Lung Resection
General anesthesia and lung separation Thoracic Surgery with Lung Resection, such as lobectomy, segmentectomy
Thoracic Surgery without Lung Resection
General anesthesia and lung separation Thoracic Surgery without Lung Resection, such as esophageal surgery, mediastinal surgery
Interventions
General anesthesia and lung separation Thoracic surgery with lung resection, such as lobectomy, segmentectomy
General anesthesia and lung separation Thoracic surgery without lung resection, such as esophageal surgery, mediastinal surgery
Eligibility Criteria
Thoracic surgical patients requiring lung isolation
You may qualify if:
- Thoracic surgical patients requiring lung isolation
- Pulmonary resection: lobectomy, segmentectomy
- Esophageal surgery and no pulmonary resection
- Mediastinal surgery and no pulmonary resection
You may not qualify if:
- Metabolic disorder
- Metabolic syndrome
- Diabetes
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology, National Taiwan University Hospital
Taipei, 100, Taiwan
Biospecimen
Exhaled breath condensate
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ya-Jung Cheng, MD, PhD
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2015
First Posted
October 22, 2015
Study Start
March 1, 2017
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
May 25, 2016
Record last verified: 2016-05